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Pseudoxanthoma elasticum (PXE) is a rare autosomal recessive disease clinically
characterised by early cutaneous alterations, and by late clinically relevant ocular, and
cardiovascular manifestations. ABCC6 genetic tests are used to confirm clinical PXE
diagnosis, but this strategy may be rather challenging when only one ABCC6 pathogenic
variant is found. A next-generation sequencing approach focusing on 362 genes related
to the calcification process and/or to inherited retinal diseases was performed on a
patient with clinical PXE diagnosis (skin papules and laxity, angioid streaks, and atrophy)
who was carrier of only one ABCC6 rare sequence variant. Beside ABCC6, several
rare sequence variants were detected which can contribute either to the occurrence
of calcification (GGCX and SERPINF1 genes) and/or to ophthalmological manifestations
(ABCA4, AGBL5, CLUAP1, and KCNV2 genes). This wide-spectrum analysis approach
facilitates the identification of rare variants possibly involved in PXE, thus avoiding invasive
skin biopsy as well as expensive and time-consuming diagnostic odyssey and allows to
broaden and to deepen the knowledge on this complex rare disease and to improve
patients’ counselling, also with a future perspective of personalised medicine.
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INTRODUCTION
Pseudoxanthoma elasticum (PXE; OMIM#264800) is an inherited disorder characterised by
calcified elastic fibres (1). The skin, around puberty, is affected by papules in flexural areas
and these alterations are the first clinical signs that are investigated and diagnosed by
dermatologists. Skin plaques and/or skin laxity may further develop during disease progression
(2). Ophthalmological manifestations (i.e., peau d’orange, angioid streaks, and comet lesions)
remain clinically silent for at least three decades. Choroidal-neovascularization (CNV) and
possibly also dystrophy and atrophy are added over time leading to progressive loss of visual
acuity (3, 4). Vascular complications are represented by peripheral artery disease, claudication
intermittent and in few cases by stroke, transient ischemic attack, and heart attack (5).
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PXE patients are typically carriers of two pathogenic variants
in the ABCC6 gene, even though in ∼10% of clinically affected
patients only one sequence variant can be detected. Moreover,
there are a number of pathologic conditions, overlapping the
PXE phenotype, where other genes, as γ-glutamyl carboxylase
(GGCX) or ectonucleotide pyrophosphatase/phosphodiesterase 1
(ENPP1), have a pathogenic role (6–8).
In addition, the heterogeneity of the PXE phenotype in terms
of number of organs involved, of disease onset and severity
suggested the involvement of modifier genes (9).
Within this context, PXE diagnosis as well as patients’
counselling can benefit from the use of next-generation
sequencing technologies allowing to facilitate and to broaden the
identification of genes that can be involved in the disease.
CASE REPORT
A 56-year-old female showed papules on neck and axillae as
well as marked skin laxity and redundance (i.e., neck, axillae,
periumbelican area, groyne, and inner thighs) (Figure 1A).
Ophthalmological examinations revealed angioid streaks
and peau d’orange. The right eye exhibited CNV requiring
2 treatments with intravitreal anti-VEGF injections, a large
peripapillary atrophy and a small iuxtafoveal scar. Optical
coherence tomography examination demonstrated also
retinal pigment epithelium (RPE)-Bruch’s membrane complex
abnormalities nasally to the fovea (Figures 1B–E).
Clinical laboratory tests (i.e., alkaline phosphatase, calcium,
phosphorus, magnesium, zinc, iron and blood clotting factors)
were within reference ranges.
Unexpectedly, molecular analysis of the ABCC6 gene by
Sanger sequencing detected only a monoallelic pathogenic
variant (c.4198G>A) (10). Multiplex ligation-dependent probe
amplification was negative.
In order to investigate the involvement of other genes, we
conducted a whole exome sequencing analysis, performed
as already described (11), focusing on 362 genes of which
41 (Supplementary Table 1) have been associated with
calcification-related diseases, according to UniProtKB, or
with the mineralization process (8, 9), whereas 321 genes
(RetNet, https://sph.uth.edu/retnet/) were known as causative of
inherited retinal diseases (e.g., macular degeneration, Stargardt
disease, retinal atrophy). Using a human genomic variant
search engine (VarSome; https://varsome.com) (12), detected
rare sequence variants (RSV) were classified as benign, likely
benign, uncertain significance, likely pathogenic and pathogenic,
according to the guidelines of American College of Medical
Genetics and Genomics and the Association for Molecular
Pathology (13). RSVs classified as benign or likely benign are
not shown. Furthermore, for each detected RSV, an additional
search was also performed in PubMed looking for functional
studies of altered sequences and for the occurrence of known
gene interactions.
Table 1 shows rare sequence variants found in patient.
A new RSV was detected on GGCX (c.193A>G) and was
classified as likely pathogenic by VarSome.
Patient was also carrier of a RSV in the Serpin
Family F Member 1 gene (SERPINF1) (c.200G>A) that
was classified of uncertain significance by VarSome.
Interestingly, this RSV determines the substitution of
Arg in position 67 with Gln. Searching of the literature
revealed that, according to mutagenesis analysis studies,
Arg67Gln and Arg69Gln have a biological significance
inducing an alteration of the nuclear import of the
protein (15).
Furthermore, a detected monoallelic ABCA4 variant
(c.1928T>G) was reported as likely pathogenic in VarSome and
in the literature (14, 16).
Finally, a non-sense pathogenic RSVs were found in CLUAP1
(c.465T>A), whereas missense RSV were detected in the AGBL5
(c.2227T>G) and KCNV2 (c.349G>A) genes. These last two
variants were classified of uncertain significance by VarSome.
DISCUSSION AND CONCLUSION
PXE is a multisystemic disease, although dermatologists, due to
early cutaneous manifestations, are frequently the first physicians
to be involved, and therefore even single case reports are
instrumental to deepen the knowledge on the challenging
complexity of this rare disease.
In particular, the GGCX gene encodes a γ-glutamyl
carboxylase, an enzyme required for the activation of vitamin
K-dependent proteins (e.g., blood coagulation factors and matrix
Gla protein-MGP). The carboxylated form of MGP is a key
factor in preventing ectopic calcification and reduced γ-glutamyl
carboxylase activity implies a decreased carboxylation of MGP,
thus favouring pathologic mineralization. Mutations in GGCX
have been described in patients with retinitis pigmentosa, cutis
laxa, and pseudoxanthoma elasticum-like skin manifestations
(17). Moreover, RSVs in ABCC6 and GGCX have been reported
in a family with PXE without coagulation disorder (6). Blood
coagulation tests performed on our patient did not reveal
decreased levels of vitamin K-dependent clotting factors,
consistently with the observation that a single RSV on GGCX
gene is not sufficient to reduce the clotting factor activity (18).
Our data support the occurrence of a GGCX and ABCC6 PXE
digenic inheritance (6).
Interestingly, we found a RSV in SERPINF1 gene, which
encodes PEDF (pigment epithelium-derived factor), a molecule
that, depending on cell type and tissue context, can modulate
the expression of osteogenic genes (e.g., ALP, Runx2, BMP-2)
as well as angiogenesis, being a potent inhibitor of ocular blood
vessels’ growth. We have already demonstrated the accumulation
of PEDF in the calcified skin (19, 20), and alterations in
PEDF expression/secretion have been also correlated to the
development of CNV and to the pathophysiology of retinal
diseases (21). PEDF is both a secreted extracellular and
intracellular protein and mutagenesis studies on Arg residues
in position 67 and 69 showed that nuclear import of PEDF
is compromised and therefore the anti-angiogenic function of
PEDF may be modified (15), further supporting the possible
involvement of this molecule in PXE.
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FIGURE 1 | (A) Skin plaques and skin laxity in the axillary area. (B,C) Colour fundus photographs of the posterior pole of the right and left eye, respectively. A large
peripapillary atrophic area (B) and angioid streak passing through the fovea (C) are evident. (D,E) Optical coherence tomography examinations of the right and left
eye, respectively. The atrophy of the retinal pigment epithelium (RPE) is evident in the right eye (arrowheads). Arrows show the abnormalities of the RPE–Bruch’s
membrane complex.












































0.000025 / / rs753681259 VUS ✓ (15)
Chr, chromosome; Freq, frequency; ExAC, Exome Aggregation Consortium; GnomAD, Genome Aggregation Database; 1000G, 1000 Genomes; /, no data available; dbSNP, single
nucleotide polymorphism database; VarSome, https://varsome.com; LP, likely pathogenic; P, pathogenic; VUS, uncertain significance; RetNet, https://sph.uth.edu/retnet/.
The ABCA4 gene encodes an ATP-binding cassette
transporter expressed in the RPE and acting as an inward-
directed retinoid flipase. RSVs in this gene determine damage
to photoreceptors and to the RPE, causing retinal dystrophies
(i.e., from mild fundus flavimaculatus to cono-rod dystrophy,
age-related macular degeneration-2, retinitis pigmentosa-like
phenotypes, up to retinal atrophy) (14) that have been also
described in PXE patients. A recent study reported a patient
with two rare variants in the ABCC6 gene and homozygosity for
ABCA4 RSV suggesting a synergic interaction causing alterations
of RPE and/or of photoreceptor function and mineralization of
the Bruch’s membrane (22). Although the inheritance of these
retinal diseases follows an autosomal recessive pattern, some
Authors have suggested that patients with only a single rare
ABCA4 variant can represent a subgroup of age-related macular
degeneration or of a late-onset Stargardt’s disease (23, 24).
Multigene analysis also detected RSVs in CLUAP1, AGBL5,
and KCNV2 genes, which are responsible for Leber congenital
amaurosis, retinitis pigmentosa, and cone dystrophy, respectively
(https://sph.uth.edu/retnet/). At present, these genes and/or their
products have been never related to PXE, nevertheless we cannot
rule out the possibility that, in combination with mutations
in other genes, these variants may play a role in patients’
ophthalmological manifestations.
In conclusion, rare sequence variants in GGCX and ABCC6 or
in ABCA4 and ABCC6 have been sporadically reported in single
PXE patients (6, 22), whereas no association has been observed
between SERPINF1 and ABCC6 genes. For the first time, all these
four genes are described in a patient clinically diagnosed as PXE,
reinforcing the hypothesis that RSVs in these genes, but possibly
also in other genes, may contribute to the development and
progression of multisystemic clinical manifestations and to the
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heterogeneity of the PXE phenotype acting in a complementary
and/or synergic manner either as causative or as modifier genes.
Physicians may experience difficulties when facing rare
diseases with clinical overlapping phenotypes and obstacles may
arise for the appropriate recognition of clinical manifestations
and for reaching a final diagnosis. Therefore, within this
context, PXE patients, as well as their medical doctor, can
benefit from the use of multigene analyses which can: (i)
facilitate the identification of rare sequence variants involved
in the disease, thus avoiding invasive approaches (i.e., skin
biopsy required to reveal elastic fibre mineralization when
ABCC6 test does not confirm clinical diagnosis), as well
as expensive and time-consuming diagnostic odyssey before
reaching a final diagnosis; (ii) deepen the knowledge on the
disease in order to better understand the heterogeneity of
phenotypic features and of diseases progression and (iii) improve
patients’ counselling also in a future perspective of personalised
medicine approaches.
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